 SOUTH SAN FRANCISCO, Calif., June 03, 2021 GLOBE NEWSWIRE -- Alector, Inc. Nasdaq: ALEC, a clinical-stage biotechnology company pioneering immuno-neurology, today announced that Shehnaaz Suliman, M.D., MBA, M.Phil., president and chief operating officer of Alector, will participate in fireside chats at the following upcoming virtual investor conferences: 